TY - JOUR
T1 - Restoration of copper metabolism and rescue of hepatic abnormalities in LEC rats, an animal model of Wilson disease, by expression of human ATP7B gene
AU - Meng, Yan
AU - Miyoshi, Ichiro
AU - Hirabayashi, Masumi
AU - Su, Mu
AU - Mototani, Yasumasa
AU - Okamura, Tadashi
AU - Terada, Kunihiko
AU - Ueda, Masatsugu
AU - Enomoto, Katsuhiko
AU - Sugiyama, Toshihiro
AU - Kasai, Noriyuki
N1 - Funding Information:
We thank Dr. Satomi Kameo and Professor Hiroshi Satoh for instructions on copper determination, and Ms. Chieko Suto for technical assistance. This work was supported by Grants-in-Aid for General Scientific Research, no. 09480244 (to N.K.), from the Ministry of Education, Culture, Sports, Science and Technology, Japan.
PY - 2004/11/5
Y1 - 2004/11/5
N2 - Hepatic abnormalities in Long-Evans Cinnamon (LEC) rats, an animal model of Wilson disease (WD), were restored by the expression of the human ATP7B cDNA under the control of CAG promoter. Expression of ATP7B transcript and protein in the liver of the transgenic rats resulted in the restoration of biosynthesis of holoceruloplasmin and biliary copper excretion. Meanwhile, transgenic rats showed striking improvements in their hepatic abnormalities, i.e., rescue from fulminant hepatitis, late onset of hepatic cholangiofibrosis, suppression of hepatocellular carcinoma and much improved survival rates. Moreover, dramatic decreases were noted both in the levels of hepatic copper and iron in transgenic rats before the occurrence of hepatitis. These results indicated that the human ATP7B product compensated for the deficiency of the endogenous rattus protein and did function in intrahepatic copper transport by secreting copper into the plasma via incorporation into ceruloplasmin and by the excretion of copper into the bile, and that ATP7B is critical to hepatic dysfunctions in WD. This first successful transgenic rescue has important implications for the gene therapy of WD.
AB - Hepatic abnormalities in Long-Evans Cinnamon (LEC) rats, an animal model of Wilson disease (WD), were restored by the expression of the human ATP7B cDNA under the control of CAG promoter. Expression of ATP7B transcript and protein in the liver of the transgenic rats resulted in the restoration of biosynthesis of holoceruloplasmin and biliary copper excretion. Meanwhile, transgenic rats showed striking improvements in their hepatic abnormalities, i.e., rescue from fulminant hepatitis, late onset of hepatic cholangiofibrosis, suppression of hepatocellular carcinoma and much improved survival rates. Moreover, dramatic decreases were noted both in the levels of hepatic copper and iron in transgenic rats before the occurrence of hepatitis. These results indicated that the human ATP7B product compensated for the deficiency of the endogenous rattus protein and did function in intrahepatic copper transport by secreting copper into the plasma via incorporation into ceruloplasmin and by the excretion of copper into the bile, and that ATP7B is critical to hepatic dysfunctions in WD. This first successful transgenic rescue has important implications for the gene therapy of WD.
KW - ATP7B
KW - Copper metabolism
KW - Fulminant hepatitis
KW - LEC rat
KW - Transgenic rat
KW - Wilson disease
UR - http://www.scopus.com/inward/record.url?scp=7044260968&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=7044260968&partnerID=8YFLogxK
U2 - 10.1016/j.bbadis.2004.06.022
DO - 10.1016/j.bbadis.2004.06.022
M3 - Article
C2 - 15511628
AN - SCOPUS:7044260968
SN - 0925-4439
VL - 1690
SP - 208
EP - 219
JO - Biochimica et Biophysica Acta - Molecular Basis of Disease
JF - Biochimica et Biophysica Acta - Molecular Basis of Disease
IS - 3
ER -